Market Research Reports

Genitourinary Drugs Market - Global Industry Size, Share, Trends, Analysis, And Forecasts 2012 - 2018




Impotency and urinary incontinence are growing concerns among people these days. Technological development is helping to overcome these age-related problems. There are various genitourinary drugs available today to cure the related illnesses.
The genitourinary drugs market is expected to grow in developing economies in the near future due to growing concerns about urinary incontinence and related illnesses. The U.S. market remains the largest market for genitourinary drugs, while Japan stands in the second place in the consumption of genitourinary drugs.
Sex hormones is the largest drug class of this market and recorded a flat growth rate owing to the increasing presence and absence of new drug launches in the past. 

Market Segmentation
  • Genitourinary Cancer
  • Bladder Cancer
  • Cervical Cancer
  • Kidney/Renal Cancer
  • Ovarian Cancer
  • Prostate Cancer
Product Segmentation
  • Sex Hormones
  • Urologicals
  • Genitourinary Anti-Infectives 
  • Gynaecologicals
This research report analyzes market segments and major geographies. It is a comprehensive study of the current market trends, growth drivers, restraints, and market projections for the coming years. It also includes an analysis of the current technological developments in the genitourinary drugs market, Porter’s five force model analysis, and detailed profiles of the top market players. The report also includes a review of the micro and macro factors significant for the existing market players and new entrants with value chain analysis.
Major geographies investigated under this report study are North America, Europe, the Asia-Pacific, and the Rest of the World.

The major players dominating this industry are Astellas, Pfizer, Betanis, Botox, Anturol, GlaxoSmithKline, Eli Lilly, Bayer AG, Merck KGaA, Merck & Co., Abbott Laboratories, Agouron Pharmaceuticals Inc., Bristol-Myers Squibb Co., Chiron Inc., Connaught Laboratories Inc., Genentech Inc., Glaxo Wellcome Plc, Hoffman-La Roche Inc., Immunex Corp., Isis Pharmaceuticals, Pharmacia & John Inc., Quadra Logic Technologies Inc., Photofrin, Rhone Poulenc Rorer Inc., Schering Plough Corp., Leucomax, and others.
Reasons for Buying this Report 
  • This report provides an overview of the major factors contributing to and limiting market growth 
  • It provides an overview of the recent technological improvements in the market to help stay updated 
  • It provides a technological growth map over time and explains its impact on the market
  • It helps to make informed business decisions by making in-depth analysis of the market, its drivers, and major challenges
  • It helps to clearly understand the changing competition dynamics and provides a complete insight of the major competitors and their strategies
  • It provides a complete outlook of the market and its future

Table of Contents


Enquiry Before Buying

Pre Book Price: $4315.5 Original Price: $4795
Share This Market Study!  

Upcoming Report

Copyright @ Transparency Market Research